Patents by Inventor Oleg Brodsky

Oleg Brodsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzisoxazole Sulfonamide Derivatives
    Publication number: 20230174522
    Abstract: The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Ring A, R1-R8, and n are defined herein. The novel benzisoxazole sulfonamide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in patients. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in patients.
    Type: Application
    Filed: September 16, 2022
    Publication date: June 8, 2023
    Inventors: Ylva Elisabet Bergman Bozikis, Oleg Brodsky, Michelle Ang Camerino, Samantha Elizabeth Greasley, Robert Louis Hoffman, Robert Arnold Kumpf, Pei-Pei Kung, Paul Francis Richardson, Paul Anthony Stupple, Scott Channing Sutton
  • Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
    Publication number: 20220251075
    Abstract: The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Ring A, Y, R1-R8, m, n and p are defined herein. The novel cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in patients. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in patients.
    Type: Application
    Filed: June 17, 2020
    Publication date: August 11, 2022
    Inventors: Oleg Brodsky, Samantha Elizabeth Greasley, Robert Louis Hoffman, Pei-Pei Kung, Paul Francis Richardson, Paul Anthony Stupple
  • Benzisoxazole Sulfonamide Derivatives
    Publication number: 20200399258
    Abstract: The present invention relates to compounds of formula (1) or pharmaceutically acceptable salts thereof, wherein Ring A, R1-R8, and n are defined herein. The novel benzisoxazole sulfonamide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in patients. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in patients.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 24, 2020
    Inventors: Ylva Elisabet Bergman Bozikis, Oleg Brodsky, Michelle Ang Camerino, Samantha Elizabeth Greasley, Robert Louis Hoffman, Robert Arnold Kumpf, Pei-Pei Kung, Paul Francis Richardson, Paul Anthony Stupple, Scott Channing Sutton
  • Crystallization of AKT3
    Patent number: 7303892
    Abstract: Provided are crystals relating to AKT3 and its various uses.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: December 4, 2007
    Assignee: Takeda San Diego, Inc.
    Inventors: Eric Adam, Oleg Brodsky, Mark W. Knuth, Jacek Nowakowski, Nikola P. Pavletich, Devon A. Thompson, Robert A. Wijnands
  • Crystallization of Glucocorticoid Receptor
    Patent number: 7241868
    Abstract: Provided are crystals relating to human Glucocorticoid Receptor and its various uses.
    Type: Grant
    Filed: October 6, 2004
    Date of Patent: July 10, 2007
    Assignee: Takeda San Diego, Inc.
    Inventors: Alexei Brooun, Oleg Brodsky, Ellen Chien, Douglas R. Dougan, Clifford D. Mol, Gyorgy Snell
  • Crystallization of 11-Beta-Hydroxysteroid Dehydrogenase type 1
    Patent number: 7241604
    Abstract: Provided are crystals relating to 11-Beta-Hydroxysteroid Dehydrogenase type 1 and its various uses.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: July 10, 2007
    Assignee: Takeda San Diego, Inc.
    Inventors: Kathleen Aertgeerts, Oleg Brodsky, Ellen Chi, Mark T. Hilgers, David J. Hosfield, Robert J. Skene